-
Mashup Score: 1
An abstract is unavailable.
Source: journals.lww.comCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 3Adults experience less fear, worry after surgery for low-risk papillary thyroid cancer - 3 day(s) ago
Adults with low-risk thyroid cancer who underwent surgery had significant reductions in cancer-related fear and worry after their procedure compared with before surgery, researchers reported. For a study published in in The Journal of Clinical Endocrinology & Metabolism, researchers surveyed adults with confirmed or likely papillary thyroid cancer about their level of thyroid cancer-related
Source: www.healio.comCategories: General Medicine News, EndocrinologyTweet-
Adults with low-risk papillary #thyroid cancer experience similar levels of fear and worry š prior to surgery whether they choose to have a hemithyroidectomy or total thyroidectomy. @EndoMedia @susieQP8 @UMichSurgery @HemOncToday Read more ā¬ļø https://t.co/mKXkuoxw9s
-
-
Mashup Score: 2
An abstract is unavailable.
Source: journals.lww.comCategories: General Medicine News, Oncologists1Tweet-
Advancements have been made in #thyroid cancer treatment, offering new hope for patients and improving outcomes. To provide deeper insights, researchers share updates on therapeutic options and innovations transforming management of this disease. https://t.co/jGnGC2wkOO https://t.co/Q5lWa8vZuJ
-
-
Mashup Score: 0Adults with Gravesā disease treated with antithyroid drugs at higher risk for some cancers - 2 month(s) ago
Adults with Gravesā disease treated with antithyroid drugs have a higher risk for multiple types of cancer compared with the general population, according to findings published in Thyroid. āPatients with Gravesā disease who received antithyroid drugs as initial treatment exhibited elevated risks of biliary tract and pancreatic, prostate, ovarian and thyroid cancers,ā Seo
Source: www.healio.comCategories: General Medicine News, EndocrinologyTweet-
š°The risk for pancreatic, #thyroid, prostate and ovarian cancers is higher for adults with Gravesā disease than the general population. Learn more ā¬ļø @HemOncToday @LiebertPub https://t.co/4q8BSjtLnG
-
-
Mashup Score: 2
A Carnegie Mellon University-led team has secured an ARPA-H award of up to $42 million to accelerate the development of implantable, cell-based bioelectronic devices that deliver patient-specific therapy and monitor disease status.
Source: www.cmu.eduCategories: General Medicine News, EndocrinologyTweet-
Carnegie Mellon Lands ARPA-H Award for Implantable Bioelectric Medicine Project for #thyroid diseases https://t.co/2cUhuhDEFd
-
-
Mashup Score: 17Paediatric thyroid lesions: lessons from recent guidelines - 3 month(s) ago
The main purpose of this commentary is to evaluate the incidence and impact of thyroid lesions in the cytological and histological evaluation of paediatric populations, through the different guidelines published over the past few years.1,2
Source: www.thelancet.comCategories: General Medicine News, EndocrinologyTweet-
OnlineāPaediatric thyroid lesions: lessons from recent guidelines https://t.co/AkMXKmfJeT #thyroid https://t.co/6wAN8yMvj9
-
-
Mashup Score: 17Paediatric thyroid lesions: lessons from recent guidelines - 3 month(s) ago
The main purpose of this commentary is to evaluate the incidence and impact of thyroid lesions in the cytological and histological evaluation of paediatric populations, through the different guidelines published over the past few years.1,2
Source: www.thelancet.comCategories: General Medicine News, EndocrinologyTweet-
OnlineāPaediatric thyroid lesions: lessons from recent guidelines https://t.co/AkMXKmfJeT #thyroid https://t.co/6wAN8yMvj9
-
-
Mashup Score: 2Once-weekly batoclimab lowers immunoglobulin for adults with uncontrolled Gravesā disease - 3 month(s) ago
Most adults who had uncontrolled Gravesā disease on antithyroid drugs responded to once-weekly subcutaneous batoclimab, according to top-line results released by Immunovant. In a phase 2a trial, people with uncontrolled Gravesā disease who had hyperthyroidism despite antithyroid drug therapy received subcutaneous once-weekly 680 mg batoclimab (Immunovant) followed by 12 weeks of
Source: www.healio.comCategories: General Medicine News, EndocrinologyTweet-
š°Once-weekly batoclimab lowered T3 and T4 below the upper limit of normal and cut immunoglobulin levels for the majority of adults with uncontrolled Gravesā disease in a phase 2a trial. Read more š #thyroid https://t.co/bxNpn36GDb
-
-
Mashup Score: 17Paediatric thyroid lesions: lessons from recent guidelines - 3 month(s) ago
The main purpose of this commentary is to evaluate the incidence and impact of thyroid lesions in the cytological and histological evaluation of paediatric populations, through the different guidelines published over the past few years.1,2
Source: www.thelancet.comCategories: General Medicine News, EndocrinologyTweet-
OnlineāPaediatric thyroid lesions: lessons from recent guidelines https://t.co/AkMXKmfJeT #thyroid https://t.co/6wAN8yMvj9
-
-
Mashup Score: 16Paediatric thyroid lesions: lessons from recent guidelines - 3 month(s) ago
The main purpose of this commentary is to evaluate the incidence and impact of thyroid lesions in the cytological and histological evaluation of paediatric populations, through the different guidelines published over the past few years.1,2
Source: www.thelancet.comCategories: General Medicine News, EndocrinologyTweet-
OnlineāPaediatric thyroid lesions: lessons from recent guidelines https://t.co/AkMXKmfJeT #thyroid https://t.co/6wAN8yMvj9
-
Advancements have been made in #thyroid cancer treatment, offering new hope for patients and improving outcomes. To provide deeper insights, researchers share updates on therapeutic options and innovations transforming management of this disease. https://t.co/jGnGC2wkOO https://t.co/Q5lWa8vZuJ